Andrew Mansfield,
Flow Chemistry Leader,
Syrris
After graduating with a degree in Applied Chemistry Andrew moved into the research sector working for a range of Pharmaceutical companies including Roche, Napp, Parke-Davis and Pfizer. From an early point in his career he began to specialize in new enabling chemical technologies and automation specializing in high throughput synthesis and purification and flow chemistry.
At Pfizer Andrew led the flow chemistry initiative working across research projects and process groups to integrate flow chemistry in Pfizer's workflow. During this time that Andrew undertook an industrial secondment in Prof. Steve Ley's group developing his knowledge in the flow field. After the Pfizer (Sandwich) site closed Andrew took his expertise and ran his own consultancy company developing batch to flow processes, training and working with flow chemistry apparatus manufactures to develop their technology and develop in-house applications. Andrew moved to Syrris in early 2015 first in a technical role to develop flow chemistry applications, moving into Product Management before taking the position as Head of Flow Chemistry Products expanding his role to cover Syrris’ complete flow chemistry portfolio.
|
|
|